This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

NATerminatedINTERVENTIONAL
Enrollment

1,750

Participants

Timeline

Start Date

July 14, 2016

Primary Completion Date

December 14, 2018

Study Completion Date

December 14, 2018

Conditions
DengueDengue Vaccines
Interventions
PROCEDURE

Blood sample collection

All participants will have an enrolment visit with collection of a blood sample and a termination contact/visit. Participants or their parents/guardians will be contacted weekly or every two weeks to monitor the occurrence of febrile episodes. Additional visits will be made if febrile episodes occur. In case of dengue suspicion, a blood sample will be collected.

Trial Locations (2)

1781

GSK Investigational Site, City of Muntinlupa

45170

GSK Investigational Site, Zapopan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02766088 - This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia | Biotech Hunter | Biotech Hunter